Bibliographie

1-     Mion F pour Société Nationale Française de GastroEntérologie, Groupe Français de Neuro-Gastroentérologie. Prise en charge de la dyspepsie. Fév 2014. Disponible sur www.snfge.org/content/cp013-prise-en-charge-de-la-dyspepsie

2-     Talley NJ et al. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005; 100: 2324-37

3-     Zagari RM, Fuccio L, Bazzoli F. Investigating dyspepsia. BMJ. 2008 Sep 15;337

4-     Veldhuyzen van Zanten SJO, Chiba N, Armstrong D et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: The CADET-HN Study. Am J Gastroenterol 2005;100:1477-88

5-     INAMI. L’usage adéquat des inhibiteurs d’acide dans le reflux gastro-œsophagien et la dyspepsie. Réunion de consensus 15 mai 2003. Disponible sur http://www.facm.ucl.ac.be/cours/Van-Bambeke/FARM22/2004-2005/guidelines…

6-     Jian R. Dyspepsie : explorer ou traiter ? Cours pour le DES de Gastro-entérologie. 2010. Disponible sur http://hepatoweb.com/DES/exposes/DES_16012010_COFFIN/JIAN.pdf

7-     Richard-Molard M. Dyspepsie chronique idiopathique. Séminaire de Tursac. Octobre 2006. Disponible sur http://hepatoweb.com/DES/DES_GO/SEMINAIRE_102006/DYSPEPSIE.pdf

8-     Ford AC, Qume M, Moayyedi P, Arents NL, Lassen AT, Logan RF, McColl KE, Myres P, Delaney BC. Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology. 2005 Jun;128(7):1838-44

9-     Lassen AT et al. Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial. Gut 2004;53:1758-1763

10-   Vakil N, Talley N, van Zanten SV, Flook N, Persson T, Björck E, Lind T, Bolling-Sternevald E; STARS I Study Group. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin Gastroenterol Hepatol. 2009 Jul;7(7):756-61

11-  Holtmann G, Talley NJ, Liebregts T et al. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006 ; 354 : 832-40

12-  Mc Coll Ket al.Symptomatic benefit from eradicating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998;339:1869-74.

13-  Blum AL et al. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998 ;339:1875-81.

14-  Calvert EL, Houghton LA, Cooper P, Morris J, Whorwell PJ. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology. 2002 Dec;123(6):1778-85

15-  Malfertheiner P, Megraud F, ­O’Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection – The Maastricht III Consensus Report. Gut 2007

16-  Humair JP, Iliescu I. Dyspepsie. 2009. Disponible sur www.hug-ge.ch/sites/interhug/files/atelier_mpr/090204_Dyspepsie.ppt

17-  Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 Apr;130(5):1377-90

18-  Moayyedi P, Soo S, Deeks JJ et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002096

19-  Hôpitaux universitaires de Genève. Dyspepsie. 2010. Disponible sur http://www.hug-ge.ch/sites/interhug/files/structures/medecine_de_premie…

20-  Bytzer P. Dyspepsia as an adverse effect of drugs. Best Pract Res Clin Gastroenterol 2010;24:109-20

21-  Von Marrewijk CJ, Mujakovic S, Fransen GA, et al. Effect and costeffectiveness of step-up versus stepdown treatment with antacids, H2 receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. Lancet 2009;373:215-25

22-  Bruley des Varannes S. Prise en charge de la dyspepsie fonctionnelle. Journées Francophones d’Hépato-gastroentérologie et d’Oncologie Digestive 2011 . Disponible sur http://www.fmcgastro.org/wp-content/uploads/file/ppt-2011/305_Stanislas…

23-  Chiba N, Veldhuyzen van Zanten SJ, Sinclair P et al. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: The Canadian Adult Dyspepsia Empiric Treatment - H pylori (CADET-Hp) randomised controlled trial. BMJ 2002;324:1012-6

24-Moayyedi P, Shelly S, Deeks JJ, Delaney B, Innes M, Forman D. WITHDRAWN:Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD001960

25-  Harvey RF, Lane JA, Nair P, et al. Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations - the Bristol Helicobacter Project. Aliment Pharmacol Ther 2010;32:394-400

26-  Ford AC, Forman D, Bailey AG, et al. A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial. Gastroenterology 2005;129:1910-7.

27-  Bazzoli F. Key points from the revised Maastricht Consensus Report: the impact on general practice. Eur J Gastroenterol Hepatol. 2001 Aug;13 Suppl 2:S3-7

28-  Mertz H, Fass R, Kodner A, et al. Effect of amitryptiline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998;93:160-5